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Abstract We have investigated the modifying effects of
epigallocatechin, a major polyphenolic constituent of green tea,
on ultraviolet-A-activated gene expression in human fibroblasts
and keratinocytes using the stress responsive enzymes: haem
oxygenase-1, interstitial collagenase and cyclooxygenase-2.
Although epigallocatechin strongly reduced ultraviolet-A-induced
haem oxygenase-1 activation in skin-derived fibroblasts, the
same compound activated collagenase and cyclooxygenase
expression. In a keratinocyte cell line, ultraviolet-A-mediated
haem oxygenase-1 over-expression was low and epigallocatechin
failed to modulate it further. In contrast to the results with
fibroblasts, ultraviolet-A activation of cyclooxygenase in kera-
tinocytes was reduced by epigallocatechin. The results indicate
that the effect of this green tea polyphenol on cellular stress
responses is complex and may involve direct effects on signal
transduction as well as changes that may be associated with its
antioxidant activity.
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1. Introduction
Polyphenols have been extensively studied as potential che-
mopreventive agents that could act against external in£amma-
tory stimuli including tumour promoting agents and solar
ultraviolet (UV) radiation [1,2]. Tea polyphenols also consid-
erably decrease the mutagenicity of di¡erent types of carcino-
gens [3,4]. Moreover, the induction of ornithine decarboxylase
and cyclooxygenase enzymes by skin tumour promoters was
signi¢cantly inhibited by topical application of green tea poly-
phenols in SENCAR mice [5]. Green tea polyphenols, cate-
chin, epicatechin, epigallocatechin, epicatechin gallate and ep-
igallocatechin gallate, are e¡ective free radical scavengers [6],
chain-breaking antioxidants [7] and scavengers of reactive ni-
trogen species [8]. The protective e¡ects of green tea polyphe-
nols have been attributed to both their antioxidant properties
as scavengers of reactive oxygen species and the activation of
phase II detoxifying enzymes [9,10]. Transcription factors
such as those included in the AP-1 complex are also modu-
lated by green tea polyphenols in human cell lines. In partic-
ular, it has been shown that treatment with green tea poly-
phenols increased mRNA levels of the immediate-early genes
c-jun and c-fos in human hepatoma cells [10] and that epigal-
locatechin gallate down-regulated lipopolysaccharide-acti-
vated nuclear factor-UB transcription in rodent macrophages
[11].
Epigallocatechin (EGC) and epigallocatechin gallate
(EGCG) are the predominant catechins in green tea [12]. It
has been shown previously that green tea polyphenols pro-
tected against UVB-induced skin carcinogenesis in mice
[5,13,14]. It was proposed that reactive oxygen species gener-
ated by UVB play a fundamental role in the process of carci-
nogenesis and that green tea polyphenols acted by quenching
such oxidant species [14]. The UVA component of solar radi-
ation exerts its biological e¡ects primarily by oxidative path-
ways [15] and antioxidants like the water-soluble ascorbic
acid, and the lipophilic K-tocopherol and butylated hydroxy-
toluene are believed to act as photo-protective agents by their
ability to scavenge reactive oxygen species generated during
UVA irradiation [16^18]. In contrast, a recent study suggests
that green tea polyphenols may have a pro-oxidant role since
they lead to the generation of hydrogen peroxide in human
cancer cell lines [19].
In this study, we have investigated the involvement of a
major polyphenolic constituent of green tea in the regulation
of UVA-activated stress response genes in human skin cells.
The result show that pre-treatment with EGC can modulate
the expression of haem oxygenase-1 (HO-1), cyclooxygenase-2
(Cox-2) and metalloproteinase-1 (MMP-1) in UVA-irradiated
dermal ¢broblasts and in UVA-irradiated transformed epider-
mal keratinocytes, but that the e¡ects observed are critically
dependent upon cell type and the speci¢c stress protein exam-
ined.
2. Materials and methods
2.1. Reagents
Cell culture media and serum were purchased from Fakola (Basel,
Switzerland). All chemicals and biochemicals were obtained from Sig-
ma Chemical Company (St. Louis, MO, USA) unless otherwise indi-
cated. Epigallocatechin was a gift from Dr Paul Quinlan, Unilever plc
(Colworth Laboratories, Bedfordshire, UK).
2.2. Cell strains and culture
The human skin ¢broblast cell line FEK4 was derived from a fore-
skin explant and cultured as described before [20]. The human oral
carcinoma cell line KB [21] was kindly provided by Prof. Jean Krut-
mann (Heinrich-Heine-University, Dusseldorf, Germany).
2.3. Cell treatments
Cells which grew in monolayers were plated (0.5U105 cells/dish) in
10 cm diameter tissue culture dishes and grown to 70^80% con£uency.
A 3 mg/ml (10 mM) EGC stock solution was prepared in water and
stored at 320‡C. Where appropriate, cells were incubated overnight
with 10 or 15 Wg/ml (33 and 50 WM respectively) EGC prior to irra-
diation. For UVA treatment, medium was removed and cells were
rinsed in isotonic PBS. During irradiation, cells were covered with a
solution of PBS containing CaCl2 and MgCl2. UVA radiation was
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provided by a broad-spectrum Uvasun 3000 lamp (Mutzhas, Munich,
Germany) and the irradiance was monitored with an IL1700 radio-
meter. Cells were irradiated through the plastic cover of the culture
dish. After irradiation, reserved medium was replaced and cell popu-
lations were incubated for various periods of time prior to RNA
extraction.
2.4. Isolation and analysis of total RNA
Total RNA was isolated by the acid guanidinium thiocyanate/phe-
nol/chloroform extraction method and subjected to Northern analysis.
Twenty-¢ve micrograms of total RNA were then loaded onto a
MOPS/formaldehyde agarose gel (1.3%), electrophoresed and trans-
ferred to a sheet of Zeta-Probe Blotting (Bio-Rad, Hercules, CA,
USA) membrane and hybridised to a 32P-labeled cDNA probe. 32P-
Labeled cDNA probes for HO-1, Cox-2 and MMP-1 were prepared
by random primed synthesis. Interstitial collagenase (MMP-1) cDNA
was kindly provided by Dr M. Wlaschek (University of Cologne,
Germany). Northern blots were also probed for glyceraldehyde phos-
phate dehydrogenase (GAPDH), as an internal control. RNA levels
were quanti¢ed by Phosphorimager (Molecular Dynamics, Sunnyvale,
CA, USA) densitometry analysis. Statistical analyses were conducted
using Minitab version 11.12 (Minitab Inc., PA, USA) and statistical
protocol was one-way analysis of variance (ANOVA), followed by
paired Student’s t-test.
3. Results
3.1. Protection against UVA-mediated HO-1 induction by EGC
in FEK4
UVA radiation regulates several stress response enzymes in
mammalian cell lines [22]. HO-1, the rate-limiting enzyme in
haem catabolism, is the major gene induced by UVA radia-
tion in human dermal ¢broblasts [23]. Fig. 1A shows that
overnight incubation of human dermal ¢broblasts (FEK4)
with 15 Wg/ml EGC signi¢cantly inhibits the basal level of
HO-1 gene expression (P6 0.01). As observed previously
[23], UVA radiation strongly up-regulated HO-1 gene expres-
sion at doses of 250 and 400 kJ/m2. Overnight pre-incubation
with EGC signi¢cantly protected against UVA up-regulation.
At UVA doses of both 250 kJ/m2 and 400 kJ/m2 we obtained
a signi¢cant decrease of HO-1 gene expression at 3 and 4 h
post irradiation with respect to EGC untreated cells
(P6 0.05). UVA irradiation of epidermoid keratinocytes
(KB) led to a small and variable increase in HO-1 gene ex-
pression (Fig. 1B). As shown in Fig. 1B, overnight incubation
with EGC did not signi¢cantly alter UVA-induced HO-1 gene
expression in KB.
Since neither EGC or its photo-degradation products
absorb UVA signi¢cantly at a concentration of 15 Wg/ml
(50 WM) (Tyrrell, Vinicombe and Rice-Evans, unpublished
results), we consider that the e¡ect of direct UV absorption
by intracellular EGC is likely to be negligible.
3.2. Increase of collagenase expression by EGC in FEK4
Another UV-activated stress response gene is interstitial
collagenase (MMP-1) [24]. MMP-1 is an extracellular matrix
degrading enzyme speci¢cally involved in collagen I and III
cleavage [25]. The enzyme is regulated by both UVB and
UVA radiation [26,27]. In our system, a peak of interstitial
collagenase expression was observed 24 h after irradiation of
dermal ¢broblasts with UVA, but no MMP-1 expression was
manifested in KB for up to 8 h (data not shown). Pre-incu-
bation of FEK4 with EGC produced a consistent and signi¢-
cant (P6 0.05) increase of MMP-1 over the basal level (Fig.
2). FEK4 irradiated with 250 or 400 kJ/m2 of UVA showed
no signi¢cant (Ps 0.05) increase of MMP-1 at 3^6 h post
irradiation with respect to sham-irradiated cells (Fig. 2). How-
ever, FEK4 incubated overnight with EGC and then UVA-
irradiated showed an increase in MMP-1 expression similar to
that obtained in sham-irradiated FEK4 pre-treated with EGC
(Fig. 2).
3.3. Modulation of UVA-mediated cyclooxygenase expression
by EGC in FEK4 and KB
Cyclooxygenase (Cox) is a haem-containing enzyme that
plays an important role in in£ammation and cancer progres-
sion [28]. Cox is encoded by two related genes, Cox-1 and
Cox-2 [29,30]. The Cox-1 gene is constitutively and ubiqui-
tously expressed, while the Cox-2 gene is only expressed at
high levels when cells are exposed to growth factors [31],
cytokines [21,32,33] and extracellular stimuli, such as UVB
radiation [21]. In both FEK4 and KB we observed an
UVA-mediated induction of Cox-2 (Fig. 3). The induction
was moderate (max. V5-fold in KB) and showed a high var-
iability due to a £uctuating basal level. Fig. 3A,B shows that
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Fig. 1. E¡ect of EGC on UVA-mediated HO-1 mRNA accumula-
tion in FEK4 (A) and KB (B). Cells were overnight incubated with
15 Wg/ml (A) or 10 Wg/ml (B) EGC and UVA-irradiated with doses
of 250 (A and B) or 400 kJ/m2 (A). The results are the mean þ S.D.
of four independent experiments.
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EGC signi¢cantly protects against UVA driven Cox-2 induc-
tion in KB. A maximal e¡ect was observed between 4 and 6 h
post irradiation at a UVA dose of 250 kJ/m2. UVA-induced
Cox-2 expression was decreased by approximately 40^50% by
EGC (Fig. 3A). In ¢broblasts, there was no protective e¡ect
of EGC on Cox-2 expression and, in contrast with KB cells,
¢broblast populations pre-incubated with EGC showed
60^70% increases in UVA-mediated Cox-2 expression at 6 h
post UVA irradiation (Fig. 3C,D).
4. Discussion
In vivo studies in rodents have shown that green tea poly-
phenols protect skin from both tumour-promoter [3] and
UVB-induced carcinogenesis [5,14]. Several hypotheses have
been proposed concerning the molecular mechanism underly-
ing such chemoprevention. Many studies claim that green tea
polyphenols exert their role through their antioxidant proper-
ties [34], while more recent papers showed that they can also
act by modulating signal transduction pathways [10,35]. In the
present study, we have compared the e¡ect of epigallocate-
chin, a green tea polyphenol, on UVA-activated gene expres-
sion in two human skin cell lines: KB transformed keratino-
cytes and FEK4 primary dermal ¢broblasts. Keratinocytes are
the ¢rst barrier to external stimuli including solar UV radia-
tion, and keratinocyte-derived cytokines are pivotal in mobi-
lising leukocytes from blood and signaling other cutaneous
cells [36,37]. Dermal ¢broblasts are less exposed to short-
wavelength solar UV (UVB) but are a target for UVA radi-
ation which penetrates more deeply into the skin. As observed
previously [38,39], regulation of gene expression by solar UV
radiation in epidermal and dermal cells is very di¡erent. In
particular, HO-1 gene expression, although strongly activated
in dermal ¢broblasts by UVA, is only weakly activated in
epidermal keratinocytes if at all [40]. Also collagenase, an
extracellular matrix-degrading enzyme involved in skin pho-
to-aging and tumour cell metastasis [25], is regulated di¡er-
ently by UVA in di¡erent cell types. In dermal ¢broblasts,
UVA induces MMP-1 gene expression to high levels through
a mechanism mediated by singlet oxygen [41], which in turn
activates interrelated autocrine loops of interleukin-1 and in-
terleukin-6 [42,43]. However, UVA is unable to induce colla-
genase production in human keratinocytes [44]. This is con-
sistent with our results showing that in KB epidermoid
keratinocytes there is neither basal or UVA-mediated expres-
sion of interstitial collagenase.
In dermal ¢broblasts, HO-1 activation is mediated by the
oxidative component of UVA [45] and, in particular, by
UVA-mediated singlet oxygen generation [46]. It is likely
that the EGC-mediated protective e¡ect observed in UVA-
irradiated ¢broblasts reported here is due to its antioxidant
properties [7]. Moreover, EGC, by protecting against UVA-
mediated increases in HO-1 expression, may decrease both
haem breakdown and the consequent enhancement in ‘free’
intracellular iron that participates in the generation of oxida-
tive membrane damage [47]. The EGC-mediated decrease in
basal levels of HO-1 mRNA accumulation observed in FEK4
cells (Fig. 1A) is an indication that EGC can lower the level of
oxidising intermediates present in cells as a result of normal
metabolism. In contrast we have observed (Fig. 1B) a lack of
an e¡ect of EGC on HO-1 levels in epidermal KB cells (for
either basal or UVA-induced expression). This could be due in
part to the fact that epidermis is less susceptible to oxidative
stress than dermis because of its greater antioxidant capacity
[48,49] that includes higher levels of intracellular glutathione
[50]. This thiol has a critical role in protecting skin cells from
photo-oxidative damage [50].
The dramatic increase in MMP-1 expression by EGC de-
scribed in Fig. 2 adds to the complexity of understanding the
role of EGC in protecting against skin damage. Skin collage-
nase levels regulate the integrity of the extracellular matrix
and its up-regulation can cause severe damage to the connec-
tive tissue, processes that are implicated in skin aging and
tumour cell metastasis. The observed increase in MMP-1
mRNA accumulation following EGC treatment of dermal ¢-
broblasts is an indication that polyphenols can interfere with
skin cell metabolism. This observation is entirely consistent
with previous studies that demonstrated that c-fos and c-jun
proteins are activated by green tea polyphenols in human cell
lines [10]. The c-fos and c-jun heterodimeric complex binds to
the AP-1 element of the promoter region of several eukaryotic
genes, including human interstitial collagenase, and thereby
regulates the basal level and the inducibility of collagenase
by a variety of agents [51]. Green tea polyphenols also stim-
ulate mitogen-activated protein kinases (MAPKs), extracellu-
lar signal-regulated kinase 2 (ERK2) and c-Jun N-terminal
kinase 1 (JNK1) in a human hepatoma cell line [10]. MAPK
signaling cascades are activated by several extracellular stimuli
and regulate steps of signal transduction that are involved in
cellular proliferation and di¡erentiation [52]. These ¢ndings
support the hypothesis that EGC could modulate collagenase
expression by activating speci¢c signal-transduction pathways.
The e¡ect of EGC on Cox-2 expression di¡ered between
UVA irradiated FEK4 and KB. UVA-induced Cox-2 expres-
sion was up-regulated in FEK4 that had been incubated over-
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Fig. 2. E¡ect of EGC on UVA-mediated MMP-1 gene expression in
FEK4. Cells were overnight incubated with or without 15 Wg/ml
EGC and UVA irradiated with doses of 250 and 400 kJ/m2. The re-
sults are the mean þ S.D. of four independent experiments.
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night with EGC (Fig. 3C,D), but decreased in EGC-treated
KB cells (Fig. 3A,B). The protective e¡ect observed in KB
was consistent with the hypothesis proposed by Agarwal et
al. [5] that green tea polyphenols prevent in vivo UV-induced
cyclooxygenase activity by scavenging UV-generated free rad-
icals. The EGC protection of UVA-mediated Cox-2 expres-
sion in keratinocytes is particularly relevant to cyclooxygenase
involvement in cutaneous tumour promotion [53]. Indeed,
oral administration of a cyclooxygenase inhibitor, indometha-
cin, to hairless mice has been shown to inhibit UV radiation-
induced erythema and skin cancer [53]. Moreover, recent stud-
ies show that human squamous cell carcinoma biopsies con-
tain higher levels of Cox-2 protein compared with normal
control skin [54]. Although protection of UVA-mediated
Cox-2 expression in KB is likely to be associated with an
antioxidant e¡ect of EGC, the mechanism by which EGC
up-regulates Cox-2 expression in UVA irradiated FEK4 re-
mains obscure (Fig. 3C,D).
Our results show that UVA induction of stress responses
genes can be modi¢ed di¡erentially by EGC according to cell
type and have described the e¡ect of polyphenols on gene
expression in human skin cells. This in vitro model allows
the investigation of a response to polyphenol treatments in
cell types (skin ¢broblasts and keratinocytes) that are a po-
tential target of external stimuli such as solar UV radiation.
We propose that the contrasting e¡ects shown by EGC in
altering the expression of stress response genes may re£ect
the ability of the compound to act both as antioxidant [7]
and as a modi¢er of the intracellular signal transduction re-
sponse [9,10,14].
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